Patients Have High Confidence in Self-Testing INR

This article originally appeared here.
Share this content:
Patients Have High Confidence in Self-Testing INR
Patients Have High Confidence in Self-Testing INR

FRIDAY, March 17, 2017 (HealthDay News) -- Most patients have high confidence in self-testing their international normalized ratio (INR), according to a study published online Feb. 23 in the Journal of Clinical Nursing.

Anne Grogan, from St. James's Hospital in Dublin, and colleagues surveyed 330 patients from three study sites who were prescribed warfarin and used INR self-testing. The survey assessed patient profile and patients' usage, issues, perceptions, confidence, and satisfaction with the self-testing system. Data were included for 178 respondents.

The researchers found that patients had high confidence in self-testing (90 percent). A high level of satisfaction was expressed with the support received, but patients perceived the need for more information in relation to support groups, side effects of warfarin, dietary information, and needle disposal. Seventy-three percent of patients agreed that they felt confident to adjust their own warfarin level. None of the patient profile factors affected this confidence. The greatest advantages of self-testing were reduced burden, more autonomy, convenience, and ease of use. Cost and communication issues were cited as the main disadvantages.

"Patients are highly satisfied with self-testing their INR and the freedom and autonomy it gives them," the authors write. "The majority of patients who self-tested also identified a confidence to move to the next level of empowerment -- self-management."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

FDA Approves Ocrevus to Treat Severe Form of ...

First drug sanctioned in United States for primary progressive multiple sclerosis

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

Study Explores Links Between Zika, GBS, Microcephaly in ...

Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly

Inadvertent HPV Vax Doesn't Up Risk of Poor Pregnancy Outcomes

Inadvertent HPV Vax Doesn't Up Risk of Poor ...

No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA

is free, fast, and customized just for you!

Already a member?

Sign In Now »